Origin
W26AI for safer cell & gene therapies
AI and Data for Cell & Gene therapies
Designing novel regulatory DNA (e.g., enhancers and promoters) to program precise therapeutic gene expression patterns - for diseases like cancer, CNS disorders and more. We're building the largest proprietary dataset of synthetic regulatory sequences across diverse cell-states.
Creating the largest patient-derived cancer single-cell dataset for licensing to pharmaceutical and AI companies. These datasets are unique as they rely on precise engineering of tumor and immune cells using our AI designed DNA switches.
Origin pivoted from developing AI-designed regulatory DNA for gene therapies to creating and licensing cancer single-cell datasets, shifting from a therapeutics company to a data provider.